ECP
CAH icon

Empyrean Capital Partners’s Cardinal Health CAH Stock Holding History

Empyrean Capital Partners’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.8M Sell
184,200
-63,600
-26% -$13.2M 1.45% 22
2026
Q1 		$52.4M Hold
247,800
– – 1.71% 17
2025
Q4 		$50.9M Sell
247,800
-109,600
-31% -$20.6M 1.77% 18
2025
Q3 		$56.1M Buy
357,400
+46,100
+15% +$7.12M 2.25% 14
2025
Q2 		$52.3M Sell
311,300
-67,700
-18% -$10M 1.75% 15
2025
Q1 		$52.2M Buy
+379,000
New +$48.3M 1.85% 16

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Empyrean Capital Partners's CAH Position: Q2 2026 in Review

Empyrean Capital Partners reduced its Cardinal Health (CAH) stake by 26% in Q2 2026, selling an estimated $13.2M and leaving 184,200 shares worth $43.8M. The position accounts for 1.45% of the portfolio, ranked #22.

Empyrean Capital Partners first reported a position in CAH in Q1 2025 and has held it in 6 quarters since. The position peaked at $56.1M in Q3 2025. 1,495 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Empyrean Capital Partners held 184,200 shares of Cardinal Health worth $43.8M as of Q2 2026.
  • Empyrean Capital Partners sold 63,600 Cardinal Health shares in Q2 2026, an estimated $13.2M.
  • Cardinal Health made up 1.45% of Empyrean Capital Partners's portfolio in Q2 2026, its #22 holding.
  • Empyrean Capital Partners first reported a position in Cardinal Health in Q1 2025 and has held it in 6 quarters since.
  • Empyrean Capital Partners's Cardinal Health position peaked at $56.1M in Q3 2025.
  • 1,495 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Empyrean Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.